| News
Technologiepark Basel celebrates its role as a driver of innovation
28.01.2021
The Technologiepark Basel will be ten years old in 2021. Over the past decade, it has supported many startups and facilitated the creation of new jobs. It will continue to do so in the future.

Technologiepark Basel celebrates its 10th anniversary (img: Technologiepark Basel, Malco Messerli Photography)
The Technologiepark Basel is an initiative launched by the economic development of the canton of Basel-Stadt, as a press release explains. Its aims were to encourage and support startups as they set up in Basel and to foster closer relationships with business and universities. This successful model is now being realized on an area of 6,700 sqm, having grown from its initial 1,400 sqm space.
The 32 startups currently located at Technologiepark Basel account for 90 percent utilization of the area. The selection process sets great store by innovations occurring on the ground and if these will create jobs within the canton of Basel-Stadt. The current 32 startups have around 230 employees overall.
Collaborations with partners in the region have also contributed to the success of the initiative so far. This approach will be further intensified in future. For example, with Basel Area Business & Innovation, the investment and innovation promotion agency, and its BaseLaunch accelerator and incubator for biotech startups. Given the positive results achieved so far, the Technologiepark’s goal for the coming years is to evolve but not expand.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Evolva launches new line for manufacturers of personal care products
Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...
Read MoreRecord figure for startups in the Basel Area
Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...
Read MoreNoema Pharma raises 103 million Swiss francs from investors
Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....
Read MoreWhy CDMO companies choose the Basel Area as their location
Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...
Read MoreBasel still the most attractive small city for business in Europe
As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...
Read MoreAriceum Therapeutics establishes subsidiary in Basel
The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...
Read More